Lorenzo-Zúñiga Vicente, Alvarez Marco A, Moreno de Vega Vicente, Seoane Agustín, Bory Felipe, Boix Jaume
Endoscopy Unit, Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Surg Laparosc Endosc Percutan Tech. 2013 Jun;23(3):266-70. doi: 10.1097/SLE.0b013e31828b8860.
The use of fluoroscopy to aid endoscopic retrograde cholangiopancreatography (ERCP) places both the patient and the endoscopy staff at the risk of radiation-induced injury. Previous reports have demonstrated a linear relationship between radiation dose and fluoroscopy duration.
To identify predictive factors of fluoroscopy time and radiation exposure to patients undergoing ERCP by using pulsed fluoroscopy.
Four hundred and four consecutive ERCPs performed from January 2010 to November 2010 at 2 tertiary centers in Spain were prospectively studied. Patients and procedural variables were analyzed. Philips BV Pulsera mobile fluoroscopy system was used on the endoscopy unit. Entrance surface dose, dose-area product, and fluoroscopy time were recorded for each patient.
A total of 404 ERCPs on 404 consecutive patients were studied (mean age 73 y). The average entrance surface dose and dose-area product were 12.0 mGy and 0.37 mGy/m2, respectively. Mean fluoroscopy time was 2.31 minutes. The biliary ducts were adequately visualized in 371 (92%) cases. After analysis with a univariable model, the factors found to significantly increase the radiation dose (P75>19.6 mGy) were as follows: alkaline phosphatase serum levels (P=0.047), balloon dilation (P=0.005), biliary stent placement (P=0.001), and ERCP diagnosis (P=<0.0001). In a multivariate analysis, only stent insertion significantly increased the radiation dose (risk ratio 4.75; 95% confidence interval, 1.84-7.63).
In this prospective analysis, multiple factors affected the radiation dose. Stent insertion was the only independent predictor significantly associated with prolonged fluoroscopy.
使用荧光透视辅助内镜逆行胰胆管造影术(ERCP)会使患者和内镜检查人员面临辐射损伤风险。既往报告显示辐射剂量与荧光透视持续时间之间存在线性关系。
通过使用脉冲荧光透视确定接受ERCP患者的荧光透视时间和辐射暴露的预测因素。
对2010年1月至2010年11月在西班牙2个三级中心连续进行的404例ERCP进行前瞻性研究。分析患者和操作变量。在内镜检查单元使用飞利浦BV Pulsera移动荧光透视系统。记录每位患者的体表入射剂量、剂量面积乘积和荧光透视时间。
对404例连续患者进行了共404例ERCP研究(平均年龄73岁)。平均体表入射剂量和剂量面积乘积分别为12.0 mGy和0.37 mGy/m²。平均荧光透视时间为2.31分钟。371例(92%)病例胆管显影良好。经单变量模型分析,发现显著增加辐射剂量(P75>19.6 mGy)的因素如下:血清碱性磷酸酶水平(P=0.047)、球囊扩张(P=0.005)、胆管支架置入(P=0.001)和ERCP诊断(P=<0.0001)。多变量分析中,仅支架置入显著增加辐射剂量(风险比4.75;95%置信区间,1.84 - 7.63)。
在这项前瞻性分析中,多种因素影响辐射剂量。支架置入是与荧光透视时间延长显著相关的唯一独立预测因素。